Replies to post #160997 on Biotech Values

[genisi]

that's still >zero. The MYGN samples came from a British registry and a TX urology practice in a upper-middle class caucasian neighborhood.

The British trial is only one of many. MYGN had data from other studies of patients from the USA such as study PRO-004 (performed by UCSF). Their data defiantly had specimens from non-caucasians. See this poster for example:

https://s3.amazonaws.com/myriad-library/Prolaris/FINAL+Freedland+_Myriad_DVA_SUO.pdf